COMMUNIQUÉS West-GlobeNewswire

Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan
23/04/2019
EAST RUTHERFORD, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
CareDx to Announce First Quarter 2019 Financial Results on May 8th, 2019
23/04/2019
BRISBANE, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on creating diagnostic solutions for organ transplant patients, today announced that it [...]
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on April 30th at 9:00 am ET
23/04/2019
CAMBRIDGE, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its first-quarter 2019 financial [...]
IntelGenx to Promote Oral Films CDMO Services at CPhI North America
23/04/2019
SAINT LAURENT, Quebec, April 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its contract development and [...]
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual Meeting
23/04/2019
BOTHELL, Wash., April 23, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Blissco Submits Application for Cannabis Oil Sales Licence
23/04/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, April 23, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
Eve & Co to Report Financial Results for the Two and Fourteen Month Periods ended December 31, 2018 on April 30, 2019
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce it will report financial results for the two and fourteen month [...]
Pluristem Therapeutics Issues Shareholder Update
23/04/2019
Recent financing provides funding through multiple potentially value-creating milestones Providing short and mid-term milestones, targeting marketing and significant contracts HAIFA, Israel, April 23, 2019 (GLOBE [...]
VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call
23/04/2019
10mcg dose selected to advance into Part B of Phase 1/2a study of VBI-1901 in recurrent GBM Expanded data from Part A of the Phase 1/2a study of VBI-1901 selected for poster presentation at ASCO Conference call and [...]
Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call
23/04/2019
MALVERN, Pa., April 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
ChemioCare Announces Initiation of PETT Based (Permeation Enhanced Transdermal Technology) Lenalidomide Program
23/04/2019
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the Company is initiating development of [...]
Maple Leaf Green World Inc. Announces Proposed Sale of Land in Henderson, Nevada, with the Proposed Use of Proceeds for the Acquisition of a Cannabis Cultivation License in Nevada
23/04/2019
CALGARY, Alberta, April 23, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) is pleased to announce it has executed a listing agreement with Cornerstone [...]
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia
23/04/2019
LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, [...]
AzurRx BioPharma Exceeds 50% Enrollment Target for Phase II OPTION Clinical Trial
23/04/2019
Enrollment in AzurRx’s Phase II OPTION study passes 50% enrollment target Initial top line data of MS1819-SD in Cystic Fibrosis Patients expected in Summer 2019 NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AzurRx [...]
ProMIS Neurosciences to Participate in the Think Equity Investor Conference
23/04/2019
Company to showcase its innovative Alzheimer’s, Parkinson’s and ALS programs TORONTO and CAMBRIDGE, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company [...]
Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019
23/04/2019
SAN DIEGO and TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
Myriad to Present Multiple Women’s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting
23/04/2019
SALT LAKE CITY, April 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present data from several [...]
Athenex Announces Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting
23/04/2019
BUFFALO, N.Y., April 23, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
EyePoint Pharmaceuticals Announces First Quarter 2019 Financial Results Release Date and Conference Call Information
23/04/2019
WATERTOWN, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will [...]

Pages